Category Archives: Medical Devices

Europe Heparin Market Key Trends & Industry Forecast 2016 – 2024

Europe Heparin Market: Snapshot

Europe is among the major regions contributing to the global heparin market owing to its developed economy and high prevalence of coagulation disorders. According to the Ageing Report published by the European Commission in 2015, the percentage of population aged above 65 years is expected to increase from 21.0% in 2013 to 32.0% in 2060. Aging is directly proportional to the rising incidence of venous thromboembolism (VTE) diseases such as deep vein thrombosis (DVT) and pulmonary embolism (PE). Hence, the demand for heparin in Europe is expected to increase in the next few years. The heparin market in Europe was valued at US$2.2 bn in 2015 and is projected to expand at a CAGR of 5.2% from 2016 to 2024 to reach US$3.5 bn in 2024.

Obtain Report Details @
http://www.transparencymarketresearch.com/europe-heparin-market.html

Heparin Most Widely Used in Hospitals across Europe

Based on end user, the heparin market in Europe has been categorized into hospitals, blood and stem cell banks, and others. Hospitals and clinics widely use heparin as a blood thinner in the treatment of various diseases related to cardiovascular, cancer, and orthopedic. Heparin such as Calcilean, Calciparine, Hepalean, Heparin Leo, and Hepalean-lok are prominently used in hospitals for surgical purposes. The hospitals segment accounted for a major share of the heparin market in Europe as most surgical procedures are often performed in hospitals.

The blood and stem cell banks segment also held a significant share of the market in 2015. Blood and stem cell banks use heparin to collect cord blood and stem cells as heparin promotes the growth of human embryonic stem cells in a defined serum-free medium.

Rapid Growth of Heparin Market Anticipated in Several European Nations

The heparin market in Europe has been segmented on the basis of geography into the following major markets: Germany, France, the U.K., Italy, Spain, Poland, Switzerland, Austria, Hungary, Belgium, Portugal, the Czech Republic, Greece, Slovakia, and Rest of Europe.

Germany accounted for the leading share in the heparin market in Europe in 2015 and is expected to continue its dominance till 2024. Key attributes to the market growth in Germany encompass burgeoning incidence of VTE among patients, resulting in the increased demand for heparin. Moreover, stringent regulations pertaining to Chinese active pharmaceutical ingredients (APIs) due to adulteration issues have attracted new players to the heparin processing and manufacturing business in Europe. Europe has been known to adhere to strict regulations pertaining to the import of heparin. For instance, in 2013, Germany-based meat company, Tönnies GmbH & Co, acquired Pharma Action, a heparin API manufacturer, and proposed to manufacture 30 metric tons of heparin API. Such developments are expected to augment the heparin market’s growth in Germany.

France, Belgium, and Portugal are anticipated to register the highest growth in the coming years. France also held the second position in the heparin market in Europe in 2015. Heparin consumption during and after surgical procedures such as knee replacement, hip surgery, appendectomy, and breast surgery is higher in France as compared to Italy, Spain, and the U.K. The increased risk of thrombosis among the geriatric population is also expected to drive the market for heparin in France.

Major players in the Europe heparin market include Sanofi SA, Pfizer, Inc., Leo Pharma, Teva Pharmaceutical Industries Ltd, and Dr. Reddy’s Laboratories.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4815

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

Advertisements

Kaposi Sarcoma Market Global Industry Volume By Region 2016 – 2024

Kaposi Sarcoma Market: Snapshot

Kaposi sarcoma (KS) refers to a type of cancer that develops from the cells lining blood vessels or lymph nodes. The cancer usually appears as tumors on mucosal surfaces or on the skin, but can also develop in body parts such as the digestive tract, or the lungs. The abnormal KS cells cause brown, purple, or red blotches on the skin, called lesions.

The global Kaposi sarcoma market features a rising number of regional vendors commanding prominent shares in their respective regional territories. Owing to the looming patent expiries of several blockbuster drugs, the market is expected to witness the entry of several new companies producing generics. The situation also presents immense growth opportunities for leading companies with new drug formulations in the next few years.

Transparency Market Research states that the global Kaposi sarcoma market will exhibit a modest 2.2% CAGR over the period between 2016 and 2024, rising from a valuation of US$118.5 mn in 2015 to US$143.2 mn by 2024.

Obtain Report Details @
http://www.transparencymarketresearch.com/kaposis-sarcoma-market.html

Chemotherapy Continues to Remain Most Preferred Course of Treatment despite High Cost

The key treatment methods for Kaposi sarcoma include immunotherapy, chemotherapy, and antiretroviral therapy. Of these, the segment of antiretroviral therapy emerged at the leading segment owing to the high incidence rate of AIDS-related Kaposi sarcoma. The segment will continue to grow at an encouraging pace in the next few years as well.

Over the report’s forecast period, however, the segment of chemotherapy is expected to exhibit growth at the most promising pace, chiefly owing to the high treatment cost and the high preference given to the treatment method by immunocompetent patients. Some of the most popular chemotherapy drugs in the market are vincristine, docetaxel, paclitaxel, bleomicin, daunorubicin, and liposomal doxorubicin. Although the high preference to this treatment method, its high cost could emerge as a key deterrent to patient population across some regions, especially across developing and less developed economies across Asia Pacific and Africa, limiting its growth prospects.

North America to Retain Dominance in Global Market despite a Low Rate of Prevalence of Kaposi Sarcoma

From a geographical standpoint, North America is presently the leading contributor of revenue to the global Kaposi sarcoma market. The region holds a leading position in the global market owing to the presence of some of the world’s leading vendors in the field and the rising costs of drugs. The North America market for Kaposi sarcoma also benefits from the high rate of diagnosis of the condition and the easy availability of drugs. The region features a low incidence rate of the disease but has been witnessing a shortage in supply of drugs required for its treatment, leading to a wide demand-supply gap and subsequently significant scope of growth.

Over the report’s forecast period, the market is expected to witness the most promising rate of growth in the Middle East and Africa region. The region is expected to lead to the heightened demand for Kaposi sarcoma drugs owing to the high rate of incidence of the disease. The high rate of prevalence of HIV/AIDS is and thus the increased prevalence of AIDS induced Kaposi sarcoma in Eastern Africa is also a key driving factor, along with the fact that awareness among people is low.

Some of the leading players operating in the immensely consolidated vendor landscape of the global Kaposi sarcoma market are Johnson & Johnson, Merck & Co., Inc., Bristol Myers Squibb, Hoffman-La Roche, Inc., Pfizer, Inc., GlaxoSmithKline plc, and Eli Lilly and Co.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3354

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

Women’s Health Rehabilitation Products Market Global Industry Volume By Region 2016 – 2024

In the last few years, the incidence of chronic illnesses has considerably increased among women. Be it the change in lifestyle or the rising geriatric populations, experts project this prevalence to continue rising in the forthcoming years as well, thus making women health rehabilitation more imperative than ever. Medical rehabilitation is a highly monitored activity considered indispensable for assisting in the improvement overall health status after a prolonged illness. Demand for women rehabilitation has therefore substantially increased in the recent years. The increasing maternal deaths, especially in developing nations, rising injuries due to road accidents, and the increasing prevalence cardiovascular ailments causing death of women have compelled governments to focus more on women health and rehabilitation.

Transparency Market Research (TMR) forecasts the global women health rehabilitation products market to reach US$4.2 bn by the end of 2024, from a valuation of US$2.6 bn in 2015. The market is therefore expected to rise at a CAGR of 5.0% between 2016 and 2024.

Obtain Report Details @
http://www.transparencymarketresearch.com/womens-health-rehabilitation-products-market.html

Rehabilitation has emerged as an important method of mitigating the burgeoning risk of chronic diseases among women.  These services are designed to improve the overall heart health, increase metabolism, expedite faster recovery, and improve hormonal profile among ailing women. Their demand has thus increased in response to the drastically changing lifestyle and dietary preferences. Integration of advanced technologies in existing rehabilitation products has further boosted prospects for their sales.

Earlier, acceptance of health rehabilitation services was a major issue across developed nations, which is now resolved with the rising awareness. However high product pricing still creates major bottlenecks for the sales of health rehabilitation products in emerging economies.

North America, Trailed by Europe, Emerged Key Contributors in 2015

Regionally, North America emerged as the key contributor in the global health rehabilitation products market in 2015, trailed by Europe. The market in North America is expected to reach US$1.5 bn by the end of 2024, from US$1 bn in 2015, rising at a CAGR of 4.9% during the period. High demand for women health rehabilitation products in both Europe and North America is attributed to the increasing number of road accidents in the last few years and the rising geriatric population. However, TMR projects Asia Pacific to exhibit the fastest CAGR due to the presence of untapped opportunities in the region. Besides this, Asia Pacific boasts a developing health care infrastructure and strong presence of skilled health care professionals, which is expected to drive demand for women health rehabilitation products in the region.

Rising Geriatric Population Boosts Demand for Treat Urinary Incontinence Products

By product type, orthopedic, pelvic pain product, urinary incontinence, pregnancy and postpartum, lymphedema, breast cancer, and osteoporosis constitute the major segments in the global women health rehabilitation products market. Of these, urinary incontinence held the dominant share in the market in 2015. It is also projected to maintain its lead through the forecast period. Increasing urinary incontinence among aged women is expected to keep demand from this segment high in the forthcoming years. The segment is expected to report a CAGR of 5.4% during the forecast period.

Some of the leading players operating in the global women health rehabilitation products market include Access Health (Victoria, Australia), Carib Rehab Ltd. (St. Michael, Barbados), GE Healthcare (Chalfont St. Giles, U.K.), GPC Medical Ltd.( New Delhi, India), Pelvic Health and Rehabilitation (San Francisco, U.S.), Rehab Plus (Timmins, Canada), Meyer Physical Therapy (New York, U.S.), Sportstek (Oakleigh, Australia), Vandana Surgical Cotton Ind. (Ajmer, India), and Win Health Medical Ltd. (Jedburgh, U.K.)

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=13022

About Us 

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

Global Intracranial Pressure Monitors Market Share by Industry Research 2015 – 2023

Upswing in Brain injuries Demands Increased Application of Intracranial Pressure Monitors

The increased prevalence of traumatic injuries and strokes has laid the ground for the immense rise of the global intracranial pressure monitors market. The upswing in the cases of brain injuries in children as well as adults has also boosted the demand for intracranial pressure monitoring remarkably across the world. However, the biggest influence on this market, which stood at US$0.94 bn in 2014, has been accredited to the substantial shift from invasive pressure monitors to non-invasive pressure monitors. This trend is expected to have an enduring effect on the dynamics of demand and supply of these monitors.

Transparency Market Research expects this market to rise at a CAGR of 6.30% between 2015 and 2023, with business opportunity reaching US$1.63 bn by the end of 2023. Untapped developing countries are anticipated to present opportunity-rich market for participants in the global market for intracranial pressure monitors.

Obtain Report Details @
http://www.transparencymarketresearch.com/intracranial-pressure-monitors-market.html

A significant growth can be witnessed in the demand for intracranial pressure monitors with their increasing application in the detection and management of various cerebrovascular disorders such as meningitis, traumatic brain injury, brain tumor, and intracerebral hemorrhage.

In 2013, the traumatic brain injury segment accounted for the biggest share in the demand for intracranial pressure monitors. TMR projects this segment to rise at a rapid CAGR of 7.70% between 2015 and 2023. The increase in violence, rising industrial as well as road accidents, and rising number of reports related to head injuries due to sports and recreational activities are the prime reasons behind the growing prevalence of traumatic brain injuries.

Growing Prevalence of Traumatic Injuries Fuels Demand for Intracranial Pressure Monitors in North America

The market for intracranial pressure monitors stretches across North America, Europe, Asia Pacific, and the Rest of the World. North America has surfaced as the biggest contributor to the intracranial monitor consumption since the past few years. The increasing prevalence of neurological disorders and traumatic injuries have amplified the application of these monitors in this region. Additionally, technical advancements in the field of pressure monitoring are expected to influence the sales volume of these monitors considerably in North America over the coming years.

Although North America will remain the leading regional market for intracranial pressure monitors during the forecast period, Asia Pacific will offer the most profitable opportunities to market players, on account of the presence of a large number of untapped markets.

Apart from this, the augmenting incidence of cerebrovascular disorders, fuelled by the increasing base of geriatric population, and the rising expenditure on healthcare, owing to surging disposable income, are also projected to boost the demand for these monitors in the near future. Europe holds the second position in the worldwide intracranial pressure monitors market.

Integra LifeSciences Corp., Medtronic Inc., and Codman & Shurtleff Inc. are leading the global intracranial pressure monitors market. The collective share of these three companies in the overall market is 53.4%. Other prominent manufacturers of intracranial pressure monitors are Haiying Medical, HeadSense Medical Inc., Raumedic AG, Spiegelberg GmbH & Co. KG., and SOPHYSA.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6445

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

Medical Waste Management Market – U.S. Industry Analysis and Forecast 2015 – 2023

A continuously expanding healthcare industry, rising numbers of diagnostic tests, and flourishing medical devices and pharmaceutical industries have significantly contributed towards the exponentially rising medical waste volumes in the U.S. The U.S. medical waste is highly regulated by strict emission, disposal, and recycling norms. It has witnessed excellent expansion in the past few years, and technological developments, emergence of advanced and innovative disposal techniques, and sustained efforts by government and non-government bodies aimed at ensuring public safety from hazardous medical waste at a sustained pace.

The Drug Enforcement Administration (DEA) has collected over 2,100 tons of prescription medicines as of September 2010 across the country, reports show. Apart from being one of the largest producers of medical waste across the globe, the U.S. also has one of the most efficient medical waste management markets of the globe. Government bodies, several NGOs, and community-based organizations are constantly guiding healthcare facilities about devising proper ways of effective recycling and disposal of medical wastes in the country.

Obtain Report Details @
http://www.transparencymarketresearch.com/us-medical-waste-management-market.html

Non-infectious Waste Takes Lion’s Share in Market

A large portion of the overall medical waste generated in the U.S. is of the non-infectious variety. In 2014, non-infectious waste accounted for a dominant share of around 63% in the U.S. waste management market. In the same year, infectious waste accounted for the second-largest, 22.6%, share of the market, TMR says.

The rising number of diagnostic tests in the country is the prime reason behind the generation of vast volumes of infectious wastes from pathological labs in the country. Rising geriatric population and the relatively larger possibility of this demographic contracting serious illnesses provides a big boost to the demand for medical services and diagnostic tests, which are major contributors to the rising volumes of medical wastes.

Non-incineration Waste Disposal Practices are Now Preferred in the U.S.

Incineration of medical wastes has traditionally been the dominant medical waste management method in the U.S. However, incineration leads to the emission of several harmful gases such as carbon monoxide, sulfur dioxide, and dioxins, which contribute to global warming. The Environment Protection Agency (EPA) has made air emission limits more stringent in the country, compelling waste management companies to switch cleaner ways of handling medical waste.

This has led to the increased adoption of non-incineration technologies such as steam autoclave treatment, non-ionization radiation treatment, a variety of chemical treatments in the past few years. Non-incineration technologies are also gaining increased popularity owing to their less capital intensive nature and the possibility of turning waste into resource efficient materials using these techniques.

Large Companies Face Stiff Competition from Small-sized Local Vendors

The U.S. market for medical waste management features the presence of a large number of small-sized local vendors and only a few large companies. In 2014, small-sized companies in the market accounted for a massive share of 53.1% in the market, while Stericycle, the most prominent large-scale company in the market held a share of 23.2%.

Mergers with and acquisitions of smaller companies are thus the most beneficial growth opportunities for new entrants and existing vendors in the market. Acquisition of smaller companies allows large-sized vendors in enhancing their operational efficiencies and expanding their service capabilities and consumer base in the U.S. medical waste management market.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=11315

About Us   

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

Nebulizers Market – India Industry Volume and Region Analysis – 2023

Thanks to growing pollution levels, the incidence of respiratory disorders is on the rise in India. This has fueled the demand for nebulizers remarkably in the country. In 2014, the India nebulizers market stood at INR575.6 mn. The dramatic growth in the cases of asthma, cystic fibrosis, and chronic obstructive pulmonary diseases is anticipated to boost the adoption of nebulizers among Indian citizens in the coming years. According to experts, the demand for these instruments will rise at a CAGR of 25.80% between 2015 and 2023 and reach an opportunity of INR4,703.4 mn by the end of 2023.

Obtain Report Details @
http://www.transparencymarketresearch.com/india-nebulizers-market.html

Aptness for all Types of Medications Drive Demand for Pneumatic Nebulizers

In India, the nebulizers market comprises pneumatic nebulizer, mesh nebulizer, ultra-sonic nebulizer, and nebulizer kits. Among these, pneumatic nebulizers are the most demanded product, owing to their aptness for almost all types of medications. In 2014, the pneumatic nebulizers segment held a share of more than 68% in the overall market, reaching to an opportunity worth INR393.53 mn. Expanding at a CAGR of 25.40% between 2015 and 2023, this opportunity is likely to increase to INR3,118.3 mn by 2023.

Mesh nebulizers emerged second in 2014 with a share of nearly 17% in the overall market. Equipped with latest technologies, these nebulizers are highly efficient and perform fast drug delivery, which is why their demand is reported to be increasing significantly. The segment is projected to register a CAGR of 27.1% between 2015 and 2023.

North Zone to Remain Dominant Regional Market for Nebulizers

The India nebulizers market is studied on the basis of its performance in the north zone, east zone, central zone, south zone, and the west zone. In 2014, north zone emerged as the market leader with a share of 35.10%. The increasing prevalence of acute respiratory diseases and chronic obstructive pulmonary disorders, triggered by the escalating level of pollution, has fueled the demand for nebulizers significantly in this zone. Analysts expect a gradual increase in this demand at a CAGR of 27.50% over the period from 2014 to 2023, ensuring the dominance of the north zone during this period.

Nebulizers are also witnessing a high demand in the east zone. According to the department of environment in West Bengal, 70% of people in Kolkata suffer from one or the other form of respiratory conditions, owing the immense environmental pollution. As the pollution continues to rise, the prevalence of respiratory diseases in this zone is projected to witness a considerable increase in the near future, boosting the demand for nebulizers.

Large Participant Pool Makes for Fragmented Competitive Landscape

The nebulizers market in India demonstrates a highly fragmented structure, thanks to the presence of a large pool of participants. Omron Healthcare, Nulife, and Philips Healthcare are at the forefront of this market. Resipirotech Med Solutions Pvt. Ltd., Becton, Dickinson and Co., PARI Respiratory Equipment Inc., Medicare Equipments (India) Pvt. Ltd., Bhasin Sons Private Ltd., Agilent Technologies, Inc., and DeVilbiss Healthcare LLC are some of the other prominent companies operating in this market.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=10655

About Us  

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

Global Cerebrospinal Fluid Management Market Key Trends & Industry Forecast 2015 – 2023


The highly competitive vendor landscape of the global cerebrospinal fluid (CSF) management market features several large and medium scale companies continuously involved in developments and innovations related to technology and applications, says a recent report by Transparency Market Research. The market is expected to witness a continued rise in development activities as companies focus on adopting better ways to effectively cater to the multidimensional and vast set of needs of the end users.

Some of the leading companies in the market are Medtronic plc, DePuy Synthes, Integra LifeSciences Holding Corporation, B. Braun Melsungen AG, Sophysa S.A., Möller Medical GmbH, BeckerSmith Medical, Inc., and Spiegelberg GmbH & Co. KG.

Transparency Market Research states that the global cerebrospinal fluid (CSF) management market will exhibit a healthy 5.5% CAGR over the period between 2015 and 2023, rising from a valuation of US$1,135.7 mn in 2014 to US$1,840.5 mn in 2023.

Obtain Report Details @
http://www.transparencymarketresearch.com/csf-management-market.html

North America to Continue to Provide Most Lucrative Revenue Prospects

In terms of product type, the segment of CSF shunts dominated the market in 2014 and is expected to retain its leading position over the forecast period as well. From a geographical standpoint, the CSF management market in North America dominated in terms of revenue contribution to the global CSF management market in 2014. The region is also likely to retain its top spot in the global market over the report’s forecast period, chiefly owing to factors such as rising geriatric population and easy availability of technologically advanced products. However, the market in Asia Pacific is projected to gain the maximum traction over the report’s forecast period owing to the increased demand for minimally invasive surgeries and a thriving medical tourism industry in emerging countries.

Rapid Pace of Development of Healthcare Infrastructure in Developing Economies to Drive Market

Factors such as the vast rise in the prevalence of brain and neurological disorders, rising geriatric population, a demographic that is highly susceptible to neurodegenerative diseases such as Alzheimer’s and Parkinson’s, and the rising scope of minimally invasive surgeries are key to the future growth potential of the global CSF management market. The market is also expected to benefit vastly from increased funding by government and private organizations across emerging economies aimed at providing effective treatment to a rising patient pool of neurological conditions.

Moreover, the promising pace of development of healthcare infrastructure, rising disposable incomes and the subsequent rise in healthcare spending of the global population, and the easy availability of technologically advanced healthcare interventions across distant corners of the globe are also expected to present promising growth opportunities to the CSF management market. These factors will especially bear significant impact in regional markets such as Latin America and Asia Pacific with a number of high-growth potential emerging economies.

High Cost of Surgeries Could Affect Market Growth to Some Extent

The market could, however, bear the brunt of challenges such as the high cost of CSF management surgeries and issues concerning the potential of infections caused by the use of CSF shunts. These factors are projected to hinder the growth prospects of the global CSF management market to a certain extent over the report’s forecast period. Nevertheless, the increased rate of awareness and improvements across the healthcare infrastructure in emerging economies such as India, China, and Brazil could present promising growth opportunities for the market to survive the negative influences of the aforesaid challenges.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2590

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/